News

The Phase 3 trial will investigate BI 201335 plus standard-of-care (SOC) in both treatment-naive and -experienced patients with chronic genotype-1 HCV. The company will recruit around 1,875 patients

The joint venture is among the first initiatives in Gumlink’s nutraceutical strategy for the future involving strategic collaborations with various industry partners, as announced in January this year.

AstraZeneca is in talks with relevant authorities on a trade name and is currently referring to the treatment by its generic name, vandetanib. AstraZeneca Specialty Care vice president

The FDA has asked the company to submit its study protocols to the INDs for further discussions in order to provide review and feedback on the proposed studies.

DKSH’s Business Unit Performance Materials is a specialty chemicals distributor and a provider of Market Expansion Services for performance materials. The Business Unit sources, develops, markets and distributes

Reportedly, the FDA warned Tec Laboratories over its StaphAseptic First Aid Antiseptic/Pain Relieving Gel, which claims on the label to kill ‘over 99.9% of MRSA, staph and strep.’

ProBiora3 contains three strains of beneficial oral bacteria that help in maintaining a healthy microbial balance in the mouth. Issuance of the patent enables Oragenics to immediately pursue

The Oxford Nanopore platform technology, GridION, consists of a scalable modular instrument and self-contained consumable cartridge. GridION is adaptable for the analysis of different types of molecules including

According to GVK BIO, GOBIOM database, which has the latest and updated information on all the biomarkers reported in various clinical and preclinical studies, will be of use